Background
Statistics suggest that clinicians are often unaware of the ultimate fate of the medications they prescribe, and may unwittingly fuel diversion and abuse, even when prescribing is well-intentioned.
Legitimate access to controlled substances is necessary for the health of patients in need of such treatment, but clinicians have a responsibility to minimize the potential for abuse and diversion. Unlikely patients could be a source of diversion, such as those with teenage family members who may take prescription medications from their medicine cabinets or purses, or patients who underestimate the dangers of sharing their medications with others. The prescriber/staff should be the first source of education for patients receiving controlled substance prescriptions so that patients understand their potential for diversion and abuse.
Archived Webinar Description
This activity will identify issues involving teen prescription medication diversion and abuse, and strategies for clinicians to reduce this risk.
Our expert faculty will describe the extent of teen prescription opioid abuse and diversion in the United States, followed by a student from a recovery high school* who will recount her experiences with prescription and other drug abuse through a personal interview.
The student will describe her trajectory of drug use to addiction, including why she began abusing prescription medication, availability/access, and drug(s) of choice.
The faculty will suggest strategies for clinicians to minimize diversion, while maintaining appropriate therapeutic access to prescription medications. These will include both patient education and tools to assist in prudent prescribing with comprehensive risk assessments, careful monitoring, and thoughtful drug selection in order to promote patient safety and limit illegitimate access to prescription medications.
* Recovery high schools are designed specifically for students who are recovering from abuse of alcohol or other drugs.
Release Date: January 31, 2010
Expiration Date: January 31, 2011
Nursing credit for this activity will be provided through January 31, 2011.
Learning Objectives
-
Explain how prescription medications may become inadvertently diverted from legitimate patients to potential abusers, especially teens
-
Summarize the potential adverse consequences of prescription drug use by persons for whom they are not prescribed
-
Specify at least 3 methods teens use to acquire prescription drugs
-
Develop strategies to teach patients to safeguard their prescriptions and not share them with others
-
Employ monitoring strategies using available tools that will help protect patients from becoming a source of abused prescription medications
Faculty
|
Carol J. Boyd, PhD, MSN, FAAN
Director, Institute for Research on Women and Gender
Deborah J. Oakley Collegiate Professor of Nursing
Professor, Women’s Studies
Research Professor, Substance Abuse Research Center
University of Michigan, Ann Arbor, Michigan
|
|
Michael J. Brennan, MD
The Pain Center of Fairfield, Fairfield, Connecticut
Senior Attending Physician, Department of Medicine, Physical Medicine, & Rehabilitation
Bridgeport Hospital, Bridgeport, Connecticut
|
Michelle Lipinski, BS
Director, Northshore Recovery High School
Beverly, Massachusetts
Allyssa
Student
Northshore Recovery High School
Beverly, Massachusetts
|
Agenda
|
High Stakes, Young Lives: Overview
Carol J. Boyd, PhD, MSN, FAAN
|
|
Extent of Prescription Medication Misuse: Focus on Teens
Carol J. Boyd, PhD, MSN, FAAN
|
|
The Road to Adolescent Drug Abuse: Interview With Recovering Student
Faculty, Recovery High School Student & Director
|
|
Q&A: Ask the Student
Participants, Faculty, Recovery High School Student & Director
|
|
Reducing Illegitimate Access to Prescription Medications
Michael J. Brennan, MD
|
|
Q&A: Ask the Faculty
Participants, Faculty
|
|
The archived webinar is approximately 1 hour in length.
|
CE Reviewers
This activity was peer-reviewed for relevance, accuracy of content, and balance of presentation by the following:
Benjamin Chavez, PharmD, BCPP
Clinical Assistant Professor, Department of Pharmacy Practice & Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey
Carol Perret, RN, MS, COHN-S
Occupational Health Nurse Specialist, Clinical Research & Occupational Medicine, Environmental & Occupational Health Sciences Institute; Nurse Manager, Employee Health Services, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
Iris G. Udasin, MD
Professor of Environmental & Occupational Medicine; Director, Environmental & Occupational Health Sciences Institute Clinical Center; Director, Employee Health Services, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
Accreditation
Physicians: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of UMDNJ-Center for Continuing and Outreach Education and PharmaCom Group. UMDNJ-Center for Continuing and Outreach Education is accredited by the ACCME to provide continuing medical education for physicians.
UMDNJ-Center for Continuing and Outreach Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses: UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing nursing education by the NJSNA, an accredited approver, by the American Nurses Credentialing Center's Commission on Accreditation. Provider Number P173-11/09-12. Provider approval is valid through November 30, 2012.
This activity is awarded 1.12 contact hour. (60 minute CH).
Provider approved by the California Board of Registered Nursing, Provider Number CEP 13780.
Pharmacists: UMDNJ-Center for Continuing and Outreach Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This course ACPE #374-9999-09-103-H05-P qualifies for 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit.
Disclosure Declaration
In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.
Faculty
Carol J. Boyd, PhD, MSN, FAAN, has disclosed the following relevant financial relationships: Member,
Scientific Advisory Board: CRS Associates, Meda Pharmaceuticals, and Reckitt Benckiser.
Michael J. Brennan, MD, has disclosed the following relevant financial relationships: Consultant: Alpharma, Cephalon, Endo Pharmaceuticals, Ipsen, King Pharmaceuticals, Pain Therapeutics, Purdue Pharma, and Wyeth; Speakers Bureau: Alpharma, Cephalon, Eli Lilly and Company, Endo Pharmaceuticals, Forest Laboratories/Cypress Bioscience, King Pharmaceuticals, Pfizer (PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals) and Purdue Pharma; Member, Scientific Advisory Board: Alpharma, Cephalon, King Pharmaceuticals, Eli Lilly and Company, Endo Pharmaceuticals, Forest Laboratories/Cypress Bioscience, Pfizer, and Purdue Pharma.
Michelle Lipinski, BS, has no relevant financial relationships to disclose.
Student Allyssa has no relevant financial relationships to disclose.
CE Reviewers
Benjamin Chavez, PharmD, BCPP; Carol Perret, RN, MS, COHN-S; and Iris G. Udasin, MD, have no relevant financial relationships to disclose.
Field Testers
Angela Eansor-Tress, RN, BSN; Syed N. Hasan, MD; Kinshasa Morton, MD; Frank Lambrinos, RPh; Andrew Scott Mathis, PharmD; and Jennifer Sormillon, BSN, have no relevant financial relationships to disclose.
Planners
UMDNJ-Center for Continuing and Outreach Education staff members, Patrick Dwyer, Director, Continuing Medical Education; Elizabeth S. Ward, Assistant Director, CME Compliance; and Felicia James, Program Manager, have no relevant financial relationships to disclose.
PharmaCom Group staff members, James Barrett, President; Angela T. Casey, Senior Editorial Director; Richard L. Abbot, Jr., Vice President Educational Programming; Jennifer A. Koenig, CMP, Senior Meeting Manager; and Maria F. DelCegno, Meetings Coordinator, have no relevant financial relationships to disclose.
Off-Label/Investigational Use
This activity does not contain information on commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
Method of Participation
In order to successfully complete this knowledge-based CE activity, the participant must officially register for the activity, log on to the activity, complete the activity assessment questionnaire, review the video presentations, and complete the pre-activity post-activity assessment questionnaire, evaluation, and registration. Upon completing this activity as designed, the participant can instantly print a CE credit letter.
Hardware/Software Requirements
Software:
Windows 98, 2000, XP, 2003, Vista, or Windows 7 and one of the following browsers–Internet Explorer 6/7, Firefox 2/3, Mozilla 1.7 or higher, Netscape 8.1 or higher. Mac OS X 10.3 or higher and one of the following browsers–Safari, Firefox 2/3. JavaScript and cookies must be enabled. Users need to have an adobe flash player plug-in on their Internet browser, if you do not have a flash player you can download it here
http://get.adobe.com/flashplayer/.
Hardware:
Windows® - Intel® Pentium® II 450MHz, AMD Athlon™ 600MHz or faster processor (or equivalent) and 128MB of RAM
Macintosh- PowerPC® G3 500MHz or faster processor, Intel Core™ Duo 1.33GHz or faster processor and 128MB of RAM
Linux® -Modem processor (800MHz or faster) and 512MB of RAM, 128MB of graphics memory
Disclaimer
The content and views presented in this educational activity are those of the presenters. It should not be inferred or assumed that they are expressing the views of the UMDNJ; PharmaCom Group; the commercial supporters of this activity, Cephalon and PriCara (Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.); or any other manufacturer of pharmaceuticals.
This material prepared is based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.
It should be noted that the clinical recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Questions
Please direct CE related questions to UMDNJ at 973-972-4267 or email ccoe@umdnj.edu.
Please direct technical questions to PharmaCom Group at 203-323-5945 or email mdelcegno@pharmacomgroup.com.
Copyright © 2010 UMDNJ-Center for Continuing and Outreach Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing and Outreach Education.